The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition
β Scribed by John A. Schinka; Ashok Raj; David A. Loewenstein; Brent J. Small; Ranjan Duara2; Huntington Potter
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 171 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2332
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
The recently developed cognitive change checklist (3CL) is comprised of four scales titled memory, executive, language, and remote recall. A previous study demonstrated that the checklist met criteria for reliability and validity in characterizing cases of mild cognitive impairment (MCI) and early dementia in a memory disorder clinic sample. In this study we examined further the reliability, validity, and efficacy of the 3CL in distinguishing among groups of normal individuals, those with cognitive complaints, amnestic and nonβamnestic MCI cases, and earlyβstage demented individuals.
Design
Scale validation study.
Setting
Alzheimer's Disease Research Center
Participants
One hundred and twentyβfive individuals who completed extensive evaluations as part of a longitudinal study of cognitive change.
Results
Scale reliabilities were found to be well within guidelines to support their use in the clinical assessment of change in global and specific cognitive domains. The factor structure of the 3CL was found to be highly similar to that originally reported. Validation support was obtained from correlational analyses that showed significant scale relationships with neurocognitive measures and with MRI ratings of medial temporal atrophy. Informant 3CL scales were found to discriminate individuals with cognitive complaints but without clinical findings from those individuals with amnestic MCI or early dementia.
Conclusion
Results extend the foundation of support for the use of the 3CL as a measure to facilitate identification of cases of MCI and early AD. Further examination of the diagnostic utility of the scale, and of its value in combination with cognitive screening measures, will also be required. Copyright Β© 2009 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
Annualized rates of cognitive change in Alzheimer's disease (AD), an important index of disease progression, show marked variability. To determine factors leading to such variability, we computed rates of change in a cohort of patients with AD tested annually with the Mini Mental State Examination (
Two measures of cognitive ability (a mental status questionnaire and a psychometric test of verbal learning and memory) were compared as predictors of three measures of self-care (self-report, informant ratings and performance testing). Self-care ability of 150 elderly in residential homes was measu
Dementia is characterized by accelerated cognitive decline before and after diagnosis as compared to normal ageing. Determining the time at which that rate of decline begins to accelerate in persons who will develop dementia is important both in describing the natural history of the disease process